Faron Pharmaceuticals Oy (LON:FARN – Get Free Report)’s share price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 176.23 ($2.28) and traded as high as GBX 220 ($2.85). Faron Pharmaceuticals Oy shares last traded at GBX 202.75 ($2.62), with a volume of 25,650 shares changing hands.
Faron Pharmaceuticals Oy Stock Performance
The firm has a market cap of £272.20 million, a price-to-earnings ratio of -5.42 and a beta of 0.36. The firm’s 50 day moving average is GBX 176.23 and its 200-day moving average is GBX 185.01. The company has a debt-to-equity ratio of 922.55, a quick ratio of 1.09 and a current ratio of 1.45.
About Faron Pharmaceuticals Oy
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
Featured Articles
- Five stocks we like better than Faron Pharmaceuticals Oy
- The Basics of Support and Resistance
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- What Are Dividend Contenders? Investing in Dividend Contenders
- MarketBeat Week in Review – 03/24 – 03/28
- How Can Investors Benefit From After-Hours Trading
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
